Sanofi

Sanofi in talks to sell stake in consumer health spinout
Pharmaphorum
Fri, 10/11/24 - 09:33 am
Sanofi
consumer health
M&A
Opella
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
Reuters
Thu, 10/10/24 - 11:20 pm
Denali
Sanofi
clinical trials
multiple sclerosis
MS
oditrasertib
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports
Reuters
Fri, 10/4/24 - 09:41 am
GSK
Sanofi
CSL
vaccines
bird flu
Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
Reuters
Fri, 10/4/24 - 09:22 am
Thermo Fisher
FDA
RSV
Beyfortus
Sanofi
AstraZeneca
drug manufacturing
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal
BioSpace
Fri, 10/4/24 - 09:17 am
Sanofi
Recordati
autoimmune disease
cold agglutinin disease
After Sanofi's first-line myeloma nod, J&J strikes back with new tranche of Darzalex data
Fierce Pharma
Mon, 09/30/24 - 09:30 am
Sanofi
JNJ
Sarclisa
Darzalex Faspro
Multiple Myeloma
FDA
FDA, after delay, clears Regeneron and Sanofi drug for COPD
BioPharma Dive
Mon, 09/30/24 - 09:25 am
Regeneron
Sanofi
Dupixent
COPD
FDA
Sanofi's Dupixent scores double COPD win in US, China
Pharmaphorum
Mon, 09/30/24 - 09:16 am
Sanofi
Regeneron
Dupixent
COPD
China
Sanofi reportedly gets PE bids for consumer health unit
Axios
Wed, 09/25/24 - 11:44 am
Sanofi
consumer health
M&A
Sanofi CEO believes company poised for growth from new drugs
Reuters
Mon, 09/23/24 - 10:32 pm
Sanofi
Pharma CEOs
Paul Hudson
Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M
Fierce Biotech
Mon, 09/23/24 - 11:33 am
Sanofi
Ventyx Biosciences
obesity
Parkinson's Disease
Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa
Fierce Pharma
Sun, 09/22/24 - 09:44 pm
Sanofi
Sarclisa
FDA
Multiple Myeloma
Sanofi’s eyes approval after MS therapy slows disease progression by 31%
Clinical Trials Arena
Sun, 09/22/24 - 09:42 pm
Sanofi
tolebrutinib
MS
multiple sclerosis
FDA
Sanofi lifts lid on MS data behind tolebrutinib’s mixed phase 3 scorecard, plans ‘24 approval filings
Fierce Biotech
Fri, 09/20/24 - 10:15 am
Sanofi
tolebrutinib
clinical trials
MS
multiple sclerosis
Sanofi readies to meet US demand for RSV antibody
BioPharma Dive
Mon, 09/16/24 - 10:17 pm
Sanofi
AstraZeneca
Beyfortus
RSV
antibodies
Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis
Fierce Biotech
Thu, 09/12/24 - 11:35 am
Sanofi
radioligands
neuroendocrine tumors
RadioMedix
Orano Med
AlphaMedix
Sanofi's innovative medicine production site inaugurated in France
European Pharmaceutical Review
Wed, 09/11/24 - 11:04 pm
Sanofi
France
drug manufacturing
biologics
vaccines
3 FDA approval dates to watch in the year’s final push
Pharma Voice
Wed, 09/11/24 - 11:39 am
FDA
Bristol Myers Squibb
KarXT
schizophrenia
Regeneron
Sanofi
Dupixent
COPD
BridgeBio
acoramidis
ATTR cardiomyopathy
Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound
BioPharma Dive
Wed, 09/11/24 - 11:19 am
Dupixent
chronic hives
Sanofi
Regeneron
FDA
Pharma’s ‘it’ therapy — a new drug class gaining steam
Pharma Voice
Wed, 09/4/24 - 11:30 am
protein degradation
Arvinas
Merck KGaA
Sanofi
Pfizer
Novartis

Pages